The global non-invasive aesthetic treatment market size was valued at USD 4.6 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 13.9% from 2021 to 2028. The market growth is attributed to the rising demand for fillers and injectables including Botox as a result of the increasing target population across the globe. According to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2018, around 3.8 million minimally invasive cosmetic surgeries were carried out in the U.S. within the age group of 55 and above. This highlights high growth prospects for the market in the country. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked first in terms of non-surgical procedures performed at a global level.
Of these, injectables, such as botulinum toxin and hyaluronic acid, were among the most popular procedures performed. The country is backed by advanced treatment options and has the highest number of surgeons at a global level. Growing awareness about fitness has increased the demand for non-invasive aesthetic treatment in developing countries. In countries, such as India, non-invasive aesthetic treatment is gaining consumer interest.
The country ranks among the top 5, in terms of surgical procedures performed. Thus, developing countries are expected to be key revenue pockets for the market in the years to come. The Covid-19 pandemic has significantly affected the non-invasive aesthetic treatment market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected.
Practitioners have also raised concerns over the downturn in patients' interest owing to a sharp cut in income level. The market is expected to witness a phase of short-term negative growth. Companies are expected to address this by offering maximum support to their customers. For instance, leading player, Allergan, has assured support for its BOTOX® operations and patient assistance.
The injectables procedure segment led the market in 2020 and accounted for the largest share of over 62%. Injectables can be easily used by surgeons and provide faster treatment with quick results and less downtime as compared to others. The others segment include hair removal, non-surgical fat reduction, sclerotherapy, and cellulite treatment. Nonsurgical fat reduction is estimated to be the fastest-growing segment during the forecast period.
Laser hair removal is gaining popularity as it saves time and is more cost-effective compared to waxing, shaving, or hair removal creams. According to the International Society of Aesthetic Plastic Surgery (ISAPS), hair removal was among the top 5 nonsurgical procedures carried out at a global level in 2019. The skin rejuvenation procedure segment is expected to grow lucratively over the forecast period owing to the high efficiency of this procedure.
North America held the largest revenue share of over 37% in 2020 owing to increasing demand for cosmetic procedures in the region. The growth in rates of cosmetic surgery procedures from the year 2000 to 2018 was compared by the American Society of Plastic Surgeons (ASPS). It was observed that the use of Botox injections increased by 845%. Thus, North America is expected to be a key revenue-generator for the global market in the coming years.
Asia Pacific is projected to register the fastest CAGR of over 14% during the forecast period due to the growing population in countries, such as China, India, and Thailand. Moreover, increasing focus on physical appearance in these developing countries is expected to play a key role in augmenting the demand for non-invasive aesthetic treatments. Thailand is projected to be one of the fastest-growing countries in the APAC region during the forecast period.
Most of the companies focus on growth strategies, such as enhancements in the existing technologies, geographical expansion, product launches, and product approvals. Recently, in 2019, one of the key players, Allergan, had launched a TV ad campaign for its brand, Botox Cosmetics for millennials. According to the American Academy of Facial Plastic and Reconstructive Surgery, in the past five years, Botox injections have increased by 22%. Some of the key players in the global non-invasive aesthetic treatment market include:
Hologic, Inc.
Allergan, Inc.
Galderma S.A.
Alma Lasers
Syneron Candela
Johnson & Johnson
Merz Pharma
Lumenis
Solta Medical
Cutera, Inc.
Revance Therapeutics, Inc.
Report Attribute |
Details |
Market size value in 2021 |
USD 8.45 billion |
Revenue forecast in 2028 |
USD 18.5 billion |
Growth Rate |
CAGR of 13.9% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Procedure, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Norway; Sweden; China; Japan; India; South Korea; Thailand; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Hologic, Inc.; Allergan, Inc.; Galderma S.A.; Alma Lasers; Syneron Candela; Johnson & Johnson; Merz Pharma; Lumenis; Solta Medical; Cutera, Inc.; Revance Therapeutics, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global non-invasive aesthetic treatment market report on the basis of procedure and region:
Procedure Outlook (Revenue, USD Million, 2016 - 2028)
Injectables
Botulinum Toxin
Calcium Hydroxylapatite
Hyaluronic Acid
Polymer Filler
Collagen
Skin Rejuvenation
Chemical Peel
Laser Skin Resurfacing
Photorejuvenation
Others
Hair Removal
Nonsurgical Fat Reduction
Sclerotherapy
Cellulite Treatment
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global non-invasive aesthetic treatment market size was estimated at USD 4.6 billion in 2020 and is expected to reach USD 8.45 billion in 2028.
b. The global non-invasive aesthetic treatment market is expected to grow at a compound annual growth rate of 13.9% from 2021 to 2028 to reach USD 18.5 billion by 2028.
b. Injectables procedures dominated the non-invasive aesthetic treatment market with a share of 62.5% in 2020. This can be attributed to the increasing demand for anti-aging injectables.
b. Some key players operating in the non-invasive aesthetic treatment market include Hologic, Inc.; Allergan, Inc.; Galderma S.A; Alma Lasers; Syneron Candela; Lumenis Ltd; Solta Medical; Cutera Inc; Merz Pharma; and Johnson & Johnson.
b. Key factors that are driving the non-invasive aesthetic treatment market growth include growing beauty consciousness among consumers and technological advancements in aesthetic devices.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.